FDA Purple Book · Reference family
desirudin (Iprivask)
desirudin is an FDA-licensed reference biologic from Bausch Health US, LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2003
Reference approved
Reference product
351(a)BLA 021271
Iprivask desirudin
Bausch Health US, LLC
- Approved
- Apr 04, 2003
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for desirudin, in chronological order.
Reference approval
Approval date of the reference desirudin product.
23 yr 6 mo ago
Frequently asked questions
Are there biosimilars approved for desirudin (Iprivask)?
No 351(k) biosimilars or interchangeable biosimilars referencing desirudin are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.